Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Minerva Neurosciences, Inc.NERV · Entity 6245 | President | June 19, 2020 | August 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Minerva Neurosciences, Inc.
Report date June 19, 2020 · Filed August 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.11 · Expires 2029-12-31 | Direct | 185,025 |
Reported balance
After 2020-06-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-19 · Grant · Acquired 185,025 · Balance 185,025 F1: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2020 Filed Aug 17, 2020 20:30 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantEmployee Stock Option (right to buy) · Derivative | 185,025 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046953 · doc4.xml · derivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,025 Underlying: Common Stock · 185,025 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:51 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantEmployee Stock Option (right to buy) · Derivative | 49,975 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-001119 · doc4.xml · derivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,975 Underlying: Common Stock · 49,975 shares Expires 2029-12-30 F1 · derivative.exercise_date: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:07 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | SaleCommon Stock | 3,113 | $7.42 | $23,098.46 |
DisclosureSEC source: 0001209191-19-060350 · doc4.xml · nonDerivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,770 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 21:43 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | SaleCommon Stock | 3,117 | $7.96 | $24,811.32 |
DisclosureSEC source: 0001209191-18-062464 · doc4.xml · nonDerivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,883 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:43 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantEmployee Stock Option (right to buy) · Derivative | 260,000 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001209191-18-062464 · doc4.xml · derivative · entry 2 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2028-12-10 F2 · derivative.exercise_date: This option vests 25% on December 11, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 21:51 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantEmployee Stock option (Right to Buy) · Derivative | 775,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0001209191-17-065220 · doc4.xml · derivative · entry 2 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,000 Underlying: Common Stock · 775,000 shares Expires 2027-12-10 F2 · derivative.exercise_date: This option vested as to 25% of the shares on December 11, 2018 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 21:51 UTC | Minerva Neurosciences, Inc. NERV · Entity 6245 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065220 · doc4.xml · nonDerivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · shares: Represents shares of the Issuer's Common Stock underlying a time-based restricted stock unit award ("RSU"). The shares subject to this RSU will vest in four (4) equal annual installments commencing on the one-year anniversary of December 11, 2017, provided the Reporting Person has provided continuous service to the Issuer through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.